IGC Pharma IGC
NYSE IGC
$0.27 +0.00 (+0.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

IGC Pharma (IGC) EBIT (2010 - 2026)

Updated

IGC Pharma (IGC) posted EBIT of -$2.46 million for FY2026, compared with -$7.45 million in FY2025.

Analysis

IGC Pharma (IGC) EBIT (2010 - 2026) Analysis & Trends

Since FY2011, IGC Pharma has reported EBIT for 16 years.

  • The FY2026 figure stands as the highest annual EBIT since FY2018.
  • Business Quant data shows IGC's EBIT at -$7.45 million in FY2025, -$9.8 million in FY2024, -$11.57 million in FY2023 and -$15.43 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 7.14 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 6.43 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 3.16 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 IGC Pharma 26.67 Mn 23.92 Mn 55,000.00 -2.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.46 Mn
Sep 30, 2025 -2.90 Mn
Jun 30, 2025 -1.91 Mn
Mar 31, 2025 -1.41 Mn
Dec 31, 2024 -1.88 Mn
Sep 30, 2024 -1.76 Mn
Jun 30, 2024 -2.40 Mn
Mar 31, 2024 -2.17 Mn
Dec 31, 2023 -3.00 Mn
Sep 30, 2023 -2.49 Mn
Jun 30, 2023 -2.14 Mn
Mar 31, 2023 -4.04 Mn
Dec 31, 2022 -2.28 Mn
Sep 30, 2022 -2.49 Mn
Jun 30, 2022 -2.80 Mn
Mar 31, 2022 -6.50 Mn
Dec 31, 2021 -2.39 Mn
Sep 30, 2021 -4.35 Mn
Jun 30, 2021 -2.19 Mn
Mar 31, 2021 -2.79 Mn
API Access

IGC Pharma EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=IGC&period=max&api_key=YOUR_API_KEY